Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes

Recruiting N/A Interventional Study
Mood Disorder (Depressive Episodes)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
594 (estimated)
Sponsor
Resilience · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual car…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years old) meeting ICD-11 criteria for a moderate to severe major depressive episode * Access to a personal smartphone and an internet connection, and cognitively able to use it independently Exclusion Criteria: * Pregnant women * Individuals under legal guardian…
Contacts

Emma Touré Cuq, PharmD

+33646396617

emma.tourecuq@resilience.care

CONTACT

Charles Ferté

charles.ferte@resilience.care

CONTACT